Advancing neurosurgery: Stryker supports brain tumor research through ongoing partnership

The facts are staggering. An estimated 1.3 million Americans are living with a brain tumor and approximately 93,000 more will be diagnosed in 2025.¹ What’s more, pediatric brain tumors are the leading cause of cancer-related death among children and adolescents ages 0-19 years.¹ Yet even with those statistics, brain tumor research remains underfunded. This is why Stryker’s Neurosurgical team is proud to partner again with the National Brain Tumor Society (NBTS) and help raise awareness and funds for brain tumor research. 

"We're proud to partner with the society to support, empower, and amplify the voice of the brain tumor community as we work to advance neurosurgery and transform lives," said Jeff Gorton, Vice President and General Manager of Stryker's Neurosurgical business.

As part of this ongoing partnership, Stryker will donate $25,000 to the NBTS to help drive awareness and funding for brain cancer research. The NBTS has already awarded more than $38 million in research grants to researchers at leading institutions, all in the pursuit of more effective treatments and ultimately a cure.

Stryker’s commitment to advancing neurosurgical care is also reflected in its innovative products. In 2019, Stryker released the Sonopet iQ Ultrasonic Aspirator, a technology that helps surgeons remove soft and hard tissue as well as work near critical anatomy. This advancement is helping to advance neurosurgical care.

To learn more about the National Brain Tumor Society or to make a donation, please visit their home page or giving platform. Together, we can support groundbreaking research and bring hope to countless individuals affected by brain tumors. 

“Brain cancer patients and their families exhibit strength and courage throughout their journey. It’s a privilege to support initiatives like this that are working to find a cure,” said Dylan Crotty, President of Stryker’s Instruments division.

David F. Arons, JD, Chief Executive Officer of the National Brain Tumor Society says, “Brain tumors are some of the toughest and most complex diseases on the planet. The generous support of sponsors like Stryker will help advance our mission and the pursuit of better outcomes for patients. Together, we are many voices with one mission.”